COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
GigaMune develops anti-tumor T cell receptors using patented methods to isolate rare TCRs from exceptional-responder immune repertoires, partnered with Massachusetts General Hospital and Harvard Medical School.